Literature DB >> 33435892

A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic.

Yapeng Cui1,2,3, Shunjiang Ni4,5,6, Shifei Shen1,2,3.   

Abstract

BACKGROUND: Testing is one of the most effective means to manage the COVID-19 pandemic. However, there is an upper bound on daily testing volume because of limited healthcare staff and working hours, as well as different testing methods, such as random testing and contact-tracking testing. In this study, a network-based epidemic transmission model combined with a testing mechanism was proposed to study the role of testing in epidemic control. The aim of this study was to determine how testing affects the spread of epidemics and the daily testing volume needed to control infectious diseases.
METHODS: We simulated the epidemic spread process on complex networks and introduced testing preferences to describe different testing strategies. Different networks were generated to represent social contact between individuals. An extended susceptible-exposed-infected-recovered (SEIR) epidemic model was adopted to simulate the spread of epidemics in these networks. The model establishes a testing preference of between 0 and 1; the larger the testing preference, the higher the testing priority for people in close contact with confirmed cases.
RESULTS: The numerical simulations revealed that the higher the priority for testing individuals in close contact with confirmed cases, the smaller the infection scale. In addition, the infection peak decreased with an increase in daily testing volume and increased as the testing start time was delayed. We also discovered that when testing and other measures were adopted, the daily testing volume required to keep the infection scale below 5% was reduced by more than 40% even if other measures only reduced individuals' infection probability by 10%. The proposed model was validated using COVID-19 testing data.
CONCLUSIONS: Although testing could effectively inhibit the spread of infectious diseases and epidemics, our results indicated that it requires a huge daily testing volume. Thus, it is highly recommended that testing be adopted in combination with measures such as wearing masks and social distancing to better manage infectious diseases. Our research contributes to understanding the role of testing in epidemic control and provides useful suggestions for the government and individuals in responding to epidemics.

Entities:  

Keywords:  COVID-19; Complex networks; Infectious disease control; Numerical simulation; Testing

Year:  2021        PMID: 33435892      PMCID: PMC7803001          DOI: 10.1186/s12879-020-05750-9

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  24 in total

1.  HIV-1 Epidemic Control - Insights from Test-and-Treat Trials.

Authors:  Salim S Abdool Karim
Journal:  N Engl J Med       Date:  2019-07-18       Impact factor: 91.245

2.  Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Authors:  Beatriz Grinsztejn; Mina C Hosseinipour; Heather J Ribaudo; Susan Swindells; Joseph Eron; Ying Q Chen; Lei Wang; San-San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Marineide Gonçalves de Melo; Kenneth H Mayer; Susan H Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2014-03-04       Impact factor: 25.071

Review 3.  Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.

Authors:  S E Reid; C A Reid; S H Vermund
Journal:  Int J STD AIDS       Date:  2004-11       Impact factor: 1.359

4.  From malaria control to eradication: The WHO perspective.

Authors:  Kamini Mendis; Aafje Rietveld; Marian Warsame; Andrea Bosman; Brian Greenwood; Walther H Wernsdorfer
Journal:  Trop Med Int Health       Date:  2009-05-26       Impact factor: 2.622

5.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

6.  Diagnostic preparedness for infectious disease outbreaks.

Authors:  Mark D Perkins; Christopher Dye; Manica Balasegaram; Christian Bréchot; Jean-Vivien Mombouli; John-Arne Røttingen; Marcel Tanner; Catharina C Boehme
Journal:  Lancet       Date:  2017-05-31       Impact factor: 79.321

7.  Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).

Authors:  Richard J Hayes; Deborah Donnell; Sian Floyd; Nomtha Mandla; Justin Bwalya; Kalpana Sabapathy; Blia Yang; Mwelwa Phiri; Ab Schaap; Susan H Eshleman; Estelle Piwowar-Manning; Barry Kosloff; Anelet James; Timothy Skalland; Ethan Wilson; Lynda Emel; David Macleod; Rory Dunbar; Musonda Simwinga; Nozizwe Makola; Virginia Bond; Graeme Hoddinott; Ayana Moore; Sam Griffith; Nirupama Deshmane Sista; Sten H Vermund; Wafaa El-Sadr; David N Burns; James R Hargreaves; Katharina Hauck; Christophe Fraser; Kwame Shanaube; Peter Bock; Nulda Beyers; Helen Ayles; Sarah Fidler
Journal:  N Engl J Med       Date:  2019-07-18       Impact factor: 176.079

Review 8.  A systematic approach to novel virus discovery in emerging infectious disease outbreaks.

Authors:  Siddharth Sridhar; Kelvin K W To; Jasper F W Chan; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Mol Diagn       Date:  2015-03-04       Impact factor: 5.568

Review 9.  The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic.

Authors:  Jasper F W Chan; Siddharth Sridhar; Cyril C Y Yip; Susanna K P Lau; Patrick C Y Woo
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

Review 10.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

View more
  8 in total

1.  Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: A modelling study.

Authors:  Trystan Leng; Edward M Hill; Robin N Thompson; Michael J Tildesley; Matt J Keeling; Louise Dyson
Journal:  PLoS Comput Biol       Date:  2022-05-27       Impact factor: 4.779

2.  From pandemic to a new normal: Strategies to optimise governmental interventions in Indonesia based on an SVEIQHR-type mathematical model.

Authors:  Benny Yong; Jonathan Hoseana; Livia Owen
Journal:  Infect Dis Model       Date:  2022-06-30

3.  Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model.

Authors:  Chao Zuo; Zeyang Meng; Fenping Zhu; Yuzhi Zheng; Yuting Ling
Journal:  Front Public Health       Date:  2022-06-15

4.  How and to what extent does the anti-social behavior of violating self-quarantine measures increase the spread of disease?

Authors:  Shinobu Utsumi; Md Rajib Arefin; Yuichi Tatsukawa; Jun Tanimoto
Journal:  Chaos Solitons Fractals       Date:  2022-05-11       Impact factor: 9.922

5.  Human Mobility and Droplet-Transmissible Pediatric Infectious Diseases during the COVID-19 Pandemic.

Authors:  Ryusuke Ae; Yoshihide Shibata; Toshiki Furuno; Teppei Sasahara; Yosikazu Nakamura; Hiromichi Hamada
Journal:  Int J Environ Res Public Health       Date:  2022-06-06       Impact factor: 4.614

6.  Country-specific optimization strategy for testing through contact tracing can help maintain a low reproduction number ([Formula: see text]) during unlock.

Authors:  Uddipan Sarma; Bhaswar Ghosh
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

7.  Comparative study of a mathematical epidemic model, statistical modeling, and deep learning for COVID-19 forecasting and management.

Authors:  Mohammad Masum; M A Masud; Muhaiminul Islam Adnan; Hossain Shahriar; Sangil Kim
Journal:  Socioecon Plann Sci       Date:  2022-01-29       Impact factor: 4.641

Review 8.  The significance of advanced COVID-19 diagnostic testing in pandemic control measures.

Authors:  Hang Fai Kwok
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.